SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:kth-201244"
 

Search: onr:"swepub:oai:DiVA.org:kth-201244" > Identification of a...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Identification of a Novel Autoimmune Peptide Epitope of Prostein in Prostate Cancer

Pin, Elisa (author)
KTH Royal Institute of Technology,KTH,Science for Life Laboratory, SciLifeLab
Henjes, Frauke (author)
KTH Royal Institute of Technology,KTH,Science for Life Laboratory, SciLifeLab
Hong, Mun-Gwan (author)
KTH Royal Institute of Technology,KTH,Science for Life Laboratory, SciLifeLab
show more...
Wiklund, Fredrik (author)
Karolinska Institutet,Karolinska Institute
Magnusson, Patrik (author)
Karolinska Institutet,Karolinska Institute
Bjartell, Anders (author)
Lund University,Lunds universitet,Urologisk cancerforskning, Malmö,Forskargrupper vid Lunds universitet,Urological cancer, Malmö,Lund University Research Groups,Skåne University Hospital
Uhlén, Mathias (author)
KTH Royal Institute of Technology,KTH,Science for Life Laboratory, SciLifeLab
Nilsson, Peter (author)
KTH Royal Institute of Technology,KTH,Science for Life Laboratory, SciLifeLab
Schwenk, Jochen M. (author)
KTH Royal Institute of Technology,KTH,Science for Life Laboratory, SciLifeLab
show less...
 (creator_code:org_t)
2016-10-24
2017
English.
In: Journal of Proteome Research. - : American Chemical Society (ACS). - 1535-3893 .- 1535-3907. ; 16:1, s. 204-216
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • There is a demand for novel targets and approaches to diagnose and treat prostate cancer (PCA). In this context, serum and plasma samples from a total of 609 individuals from two independent patient cohorts were screened for IgG reactivity against a sum of 3833 human protein fragments. Starting from planar protein arrays with 3786 protein fragments to screen 80 patients with and without PCA diagnosis, 161 fragments (4%) were chosen for further analysis based on their reactivity profiles. Adding 71 antigens from literature, the selection of antigens was corroborated for their reactivity in a set of 550 samples using suspension bead arrays. The antigens prostein (SLC45A3), TATA-box binding protein (TBP), and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) showed higher reactivity in PCA patients with late disease compared with early disease. Because of its prostate tissue specificity, we focused on prostein and continued with mapping epitopes of the 66-mer protein fragment using patient samples. Using bead-based assays and 15-mer peptides, a minimal peptide epitope was identified and refined by alanine scanning to the KPxAPFP. Further sequence alignment of this motif revealed homology to transmembrane protein 79 (TMEM79) and TGF-beta-induced factor 2 (TGIF2), thus providing a reasoning for cross-reactivity found in females. A comprehensive workflow to discover and validate IgG reactivity against prostein and homologous targets in human serum and plasma was applied. This study provides useful information when searching for novel biomarkers or drug targets that are guided by the reactivity of the immune system against autoantigens.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

autoimmunity
prostate cancer
prostein
planar microarray
suspension bead array
profiling epitope mapping
Human Protein Atlas
antigen
peptide
antigen
autoimmunity
epitope mapping
Human Protein Atlas
peptide
planar microarray
profiling
prostate cancer
prostein
suspension bead array

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view